Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
NCT ID:
NCT00000912
Eligibility Criteria:
Inclusion Criteria
Patients may be eligible for this study if they:
* Are HIV-positive.
* Have current virologic failure (2 consecutive HIV blood levels above 1,000 copies/ml) while on PIs.
* Are over 13 years of age (consent of parent or guardian required if under 18).
* Agree to practice abstinence or use effective methods of birth control during the study and for 90 days after.
Exclusion Criteria
Patients will not be eligible for this study if they:
* Have hepatitis within 90 days prior to study entry.
* Have a history of a peripheral neuropathy within 60 days of study entry.
* Have an unexplained temperature for a 7-day period.
* Have chronic diarrhea within 30 days prior to study entry.
* Have cancer requiring chemotherapy.
* Received any therapy for infection or other illness within 30 days prior to study entry.
* Have received certain other medications.
* Are pregnant or breast-feeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
13 Years
Study:
NCT00000912
Study Brief:
Protocol Section:
NCT00000912